APA Citatie

Sachdeva, M., & Dhingra, S. (2015). Obinutuzumab: A FDA approved monoclonal antibody in the treatment of untreated chronic lymphocytic leukemia. Int J Appl Basic Med Res.

Chicago Style citaat

Sachdeva, Mamta, en Sameer Dhingra. "Obinutuzumab: A FDA Approved Monoclonal Antibody in the Treatment of Untreated Chronic Lymphocytic Leukemia." Int J Appl Basic Med Res 2015.

MLA citatie

Sachdeva, Mamta, en Sameer Dhingra. "Obinutuzumab: A FDA Approved Monoclonal Antibody in the Treatment of Untreated Chronic Lymphocytic Leukemia." Int J Appl Basic Med Res 2015.